Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02995941 · ClinicalTrials.gov registry record
Shoulder Symptom Irritability Scale: A Single-Blinded Observational Study
A clinical trial, sponsored by St. Luke's Hospital and Health Network, Pennsylvania.
- Completed
- Registry status
- 138
- Enrollment target
NCT02995941: Completed study, sponsored by St. Luke's Hospital and Health Network, Pennsylvania.
NCT02995941 is a clinical trial that has completed, run by St. Luke's Hospital and Health Network, Pennsylvania. The registered enrollment target is 138 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02995941 has completed, sponsored by St. Luke's Hospital and Health Network, Pennsylvania.
- COMPLETED
- Registry status
- 138 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the reliability and use of the shoulder symptom irritability classification system for the purposes of determining an appropriate treatment intensity to better help people with shoulder pain.
Primary Outcome
Two different raters will individually rate the shoulder symptom irritability of each patient. Raters will be blinded to the other's rating.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2016-12 |
| Est. Completion | 2017-07 |
What the finished NCT02995941 record still lists
NCT02995941 is an observational study that tracks outcomes without assigning an intervention. The registered 138 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02995941 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02995941 about?
NCT02995941 is a clinical study titled "Shoulder Symptom Irritability Scale: A Single-Blinded Observational Study". The purpose of this study is to examine the reliability and use of the shoulder symptom irritability classification system for the purposes of determining an appropriate treatment intensity to better help people with shoulder pain.
What is the current status of trial NCT02995941?
This trial is currently completed. The enrollment target is 138 participants. The study started on 2016-12. Estimated completion is 2017-07.
Who is sponsoring clinical trial NCT02995941?
This trial is sponsored by St. Luke's Hospital and Health Network, Pennsylvania, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04402788 · 138 participants · Phase 2
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
- NCT04883255 · 138 participants · Early Phase 1
Cannabis Use, Cognition, and the Endocannabinoid System in HIV
- NCT05620784 · 138 participants · Phase 3
Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP
- NCT05832086 · 138 participants · Phase 2
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia